Related references
Note: Only part of the references are listed.Intravitreal fluocinolone acetonide 0.19 mg (Iluvien (R)) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients
Anne Studsgaard et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)
The Use of Sustained Release Intravitreal Steroid Implants in Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Didar Abdulla et al.
OPHTHALMOLOGY AND THERAPY (2022)
Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema
Lucy Joanne Kessler et al.
PHARMACEUTICS (2022)
Uveitis Therapy: The Corticosteroid Options
Lianna M. Valdes et al.
DRUGS (2020)
Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2020)
Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye - evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN(R))
Bahram Bodaghi et al.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2020)
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial
Jennifer E. Thorne et al.
OPHTHALMOLOGY (2019)
MUST Beg to Differ
Thomas Albini et al.
Ophthalmic Surgery Lasers & Imaging Retina (2019)
Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment Twelve-Month Results
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2019)
Management of noninfectious posterior uveitis with intravitreal drug therapy
Hui Yi Tan et al.
CLINICAL OPHTHALMOLOGY (2016)
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis Fifty-foureMonth Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
John H. Kempen et al.
OPHTHALMOLOGY (2015)
A Comparison Between the Fluocinolone Acetonide (Retisert) and Dexamethasone (Ozurdex) Intravitreal Implants in Uveitis
Cheryl A. Arcinue et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2013)
Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2012)
Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior Uveitis
Careen Lowder et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Three-Year Follow-up of a Randomized Trial Comparing Focal/Grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular Edema
ARCHIVES OF OPHTHALMOLOGY (2009)
Treatment of posterior uveitis with a fluocinolone acetonide implant - Three-year clinical trial results
David G. Callanan et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants
Debra A. Goldstein et al.
ARCHIVES OF OPHTHALMOLOGY (2007)
Share Paper
